ACTA FAC MED NAISS 2022;39(2):165-172 |
Review article
UDC:
Running title:
Asthma and COVID-19
Asthma as a Risk Factor for the Progression
Department of Microbiology, Al-Kindy College of Medicine, University of
Baghdad, Baghdad, Iraq
SUMMARY
Background: Asthma is one of the most common chronic respiratory
diseases in the world, standing for the most frequent cause for
hospitalization and emergency cases. Respiratory viruses are the most
triggering cause.
Aim: To assess the role of viral infections, especially COVID-19, in the
pathogenesis of asthma initiation and exacerbations.
Method: Electronic search was done for the manuscripts focusing on
asthma as a risk factor for complications after COVID-19 infection. The
outcomes were titles, materials, methods and classified studies related
or not related to the review study. Three hundred publications were
identified and only ten studies were selected for analysis. Seven
studies were review, one retrospective, one longitudinal cohort study
and one letter to the editor.
Results: The included literature sources have highlighted different
effect of asthma on COVID-19 progression. Asthma can be triggered by
this virus and asthmatic patients with COVID-19 should not stop their
treatment. Others suggest that asthma does not appear to be a
significant risk factor for developing severe COVID-19 requiring
hospitalization or intubation.
Conclusions: Asthma is
considered as comorbidity factor leading to complications and mortality
in subjects infected with COVID-19.
Keywords: COVID-19, asthma, immunity
Corresponding author:
Batool Mutar Mahdi
e-mail: batoolmutar@kmc.uobaghdad.edu.iq